Peptide Stacking for Muscle Preservation on GLP-1s: The Complete Protocol
GLP-1 agonists cause muscle loss alongside fat. Learn which peptides to stack — TB-500, BPC-157, GHK-Cu, MOTS-C — to preserve lean mass and optimize body recomposition during weight loss.

GLP-1 agonists cause muscle loss alongside fat. Learn which peptides to stack — TB-500, BPC-157, GHK-Cu, MOTS-C — to preserve lean mass and optimize body recomposition during weight loss.
Peptide South Africa Research Research TeamPeptide Science & Longevity

The Muscle Loss Problem Nobody Talks About
GLP-1 receptor agonists — semaglutide, tirzepatide, retatrutide — are the most effective weight loss tools ever put in a clinical trial. But they come with a cost most people don't fully appreciate until they've lost 40 pounds and look in the mirror: a significant portion of that weight is muscle.
Studies of semaglutide show roughly 25–40% of total weight lost comes from lean mass rather than fat. Even retatrutide, the most sophisticated of the triple agonists, averages 1 pound of muscle loss for every 5–7 pounds of fat — a better ratio, but still meaningful at the scale of 70+ pound weight loss.
Lose 70 pounds with 25% coming from muscle? That's 17.5 pounds of muscle mass gone. For a 55-year-old with age-related sarcopenia already working against them, that's a serious problem.
The solution isn't to avoid GLP-1s. It's to stack strategically.
Why Muscle Loss Happens on GLP-1s
GLP-1 agonists work primarily by reducing appetite and caloric intake. When you're running a large caloric deficit, your body looks for energy from everywhere — including muscle protein. Several factors amplify this:
- Reduced protein intake — when eating 1,000-1,500 calories per day, most people don't hit protein targets
- Metabolic adaptation — the body downregulates energy expenditure, slowing BMR
- Reduced activity — many patients become less active as appetite suppression also suppresses drive
- Blunted anabolic signaling — GLP-1 pathways don't directly stimulate muscle protein synthesis
- Resistance training minimum: 3 sessions per week, compound movements (squat, deadlift, press, row)
- Protein target: 0.8–1g per pound of body weight — non-negotiable on GLP-1s
- Zone 2 cardio: 20–30 minutes daily for metabolic conditioning without catabolic stress
- Sleep: 7–9 hours. Growth hormone is released during deep sleep; disrupting this negates much of your stack
- DEXA scans every 8–12 weeks (most accurate)
- Bioelectrical impedance scales (directional trend, not absolute accuracy)
- Progress photos every 4 weeks
- Strength benchmarks in the gym (if your lifts are holding, your muscle is holding)
Peptide South Africa Research lets you log every protocol variable — peptide doses, training sessions, body metrics — in one place so you can spot correlations across your full stack rather than guessing.
Frequently Asked Questions
Q: Do I need to cycle TB-500 and MOTS-C?
A: Yes. Both are typically run in 4–6 week on/2–4 week off cycles. BPC-157 and GHK-Cu can be run continuously. Check your body's response and adjust accordingly.
Q: Can I add tesamorelin for even more lean mass preservation?
A: Tesamorelin is one of the most studied peptides for fat loss with lean mass preservation, particularly visceral fat. It stacks well with this protocol. Add it at 1–2mg nightly, preferably on an empty stomach to preserve GH pulse dynamics.
Q: Is this stack safe alongside a GLP-1 prescription?
A: The peptides in this stack operate through distinct mechanisms from GLP-1 agonists. No known interactions. That said, always discuss your full protocol with a prescribing physician. This is educational information, not medical advice.
Q: How long before I see results from the stack?
A: BPC-157 and GHK-Cu effects on tissue recovery are often noticed within 2–3 weeks. MOTS-C metabolic changes typically show up in 4–6 weeks. TB-500 anabolic effects are best measured over an 8–12 week period. Track your strength numbers as a leading indicator.
Q: What order do I inject multiple peptides?
A: Reconstitute each separately. Draw from each vial individually into one syringe if they're going to the same injection site — or inject at different sites to reduce local irritation. Do not mix peptides in the same vial.
Manage Your Stack with Peptide South Africa Research
Running four peptides alongside a GLP-1 prescription is a lot to track manually. Peptide South Africa Research makes it manageable: log every dose, set injection reminders, track your body metrics, and see your full protocol at a glance.
Download Peptide South Africa Research and build the protocol that actually preserves your gains while you cut.
#peptide stacking#GLP-1#muscle preservation#body recomposition#TB-500#BPC-157#GHK-Cu#MOTS-C#weight lossShare this articleTwitterLinkedInTrack Your Peptide Protocols
Use Peptide South Africa Research to log injections, calculate doses, access our peptide library, and optimize your protocols.
Download Peptide South Africa ResearchExplore More Peptide ResourcesFree peptide calculators·Peptide research hub·Peptide glossary·Semaglutide guide·BPC-157 guide·Best peptide calculator
More in Protocols
GLP-1 Discontinuation: How to Maintain Weight Loss After Stopping
GLP-1 peptides can produce major weight loss, but stopping often brings weight regain. Learn how to plan tapering, tracking, protein, training, and maintenance.
How to Reconstitute and Dose NAD+: A Practical Guide
Learn the proper technique for reconstituting NAD+ vials, understanding concentration calculations, and building an effective dosing protocol for your research needs.
How to Mix BPC-157 and TB-500: A Beginner's Complete Guide
How to Mix BPC-157 and TB-500: A Beginner's Complete Guide You got your first peptide vials and now you are staring at two bottles of powder and a box of needles. Here is exactly how to mix BPC-157 and TB-500 without overthinking it.